![]() |
By Evelyn Pringle (about the author) Page 5 of 5 page(s)
"For example," Dr Levine points out, "in 2002 the journal Prevention & Treatment analyzed 47 studies that had been sponsored by drug companies on Prozac, Paxil, Zoloft, Effexor, Celexa, and Serzone, and it reported that in the majority of the trials, the antidepressant failed to outperform a sugar pill placebo."
Another of the world's leading authorities on SSRI's, Dr David Healy, also says that the effectiveness of SSRI's has been exaggerated, and the actual data reveals that only one in 10 patients on SSRI's can be shown to respond specifically to the drug rather than a nonspecific factor or a placebo.
Dr Healy is the author of numerous books on psychiatric drugs including, "The Antidepressant Era" and "The Creation of Psychopharmacology."
He says that, in prescribing SSRI's to pregnant women, he is concerned about "the benefit-harm trade-off," because "without any benefits, the child runs all the risks including the neonatal withdrawal syndrome and birth defects."
Dr Healy points out that the CDC study focuses on linking particular specific defects to particular drugs, and once you do this, "you end up with very small numbers in each group and not a lot of significant findings," he says.
Families seeking legal advice regarding SSRI birth defects can contact the Baum, Hedlund, Aristei, Goldman & Menzies Law Firm at: (800) 827-0087; http://www.baumhedlundlaw.com/
Evelyn Pringle
evelyn-pringle@sbcglobal.net
(Written as part of the Antidepressant Birth Defect Litigation Monthly Round-Up, Sponsored by Baum Hedlund's Pharmaceutical Antidepressant Litigation Department)
www.paxilbirthdefect.com/
www.pphnlawyers.com
(Evelyn Pringle is a regular columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America)
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| 1 comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |